ARVINAS INC. - COMMON
24.48
26-11月-24 16:45:00
15 分の遅延
株式
-0.67
-2.66%
本日の幅
24.41 - 25.24
ISIN
N/A
ソース
NASDAQ
-
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
27 2 2024 07:00:07 提供 Nasdaq GlobeNewswire
-
Arvinas Announces Chief Financial Officer Transition
20 2 2024 16:05:04 提供 Nasdaq GlobeNewswire
-
20 2 2024 07:00:44 提供 Nasdaq GlobeNewswire
-
06 2 2024 06:45:00 提供 Nasdaq GlobeNewswire
-
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
01 2 2024 16:30:20 提供 Nasdaq GlobeNewswire
-
Arvinas Appoints Jared Freedberg as General Counsel
16 1 2024 17:01:06 提供 Nasdaq GlobeNewswire
-
05 12 2023 13:33:42 提供 Nasdaq GlobeNewswire
-
28 11 2023 17:05:13 提供 Nasdaq GlobeNewswire
-
Arvinas Announces Oversubscribed $350 Million Private Placement
27 11 2023 07:00:10 提供 Nasdaq GlobeNewswire
-
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07 11 2023 07:00:34 提供 Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
02 11 2023 07:00:59 提供 Nasdaq GlobeNewswire
-
22 10 2023 07:00:58 提供 Nasdaq GlobeNewswire
-
Arvinas Gives Back to Local Greater New Haven Community in Second Annual Impact Day
18 10 2023 07:00:27 提供 Nasdaq GlobeNewswire
-
Arvinas Announces Upcoming Bavdegalutamide Poster Presentation at ESMO Congress 2023
15 10 2023 18:07:41 提供 Nasdaq GlobeNewswire
-
15 10 2023 18:05:45 提供 Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
01 9 2023 07:00:10 提供 Nasdaq GlobeNewswire
-
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
08 8 2023 07:00:18 提供 Nasdaq GlobeNewswire
-
Arvinas Announces Changes to its Board of Directors
15 6 2023 16:30:26 提供 Nasdaq GlobeNewswire